ESR1 and breast cancer: Breast cancer can be divided into three biologic subtypes, based on biomarkers, such as the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth receptor 2 (HER2); each subtype exhibits a distinct prognostic significance10.